The archetypal imaging characteristics of meningiomas are among the most stereotypic of
all central nervous system (CNS) tumors. In the era of plain film and ventriculography …

Localized proton magnetic resonance spectroscopy (MRS) of the human brain, first reported
more than 20 years ago, 1–3 is a mature methodology that is used clinically in many medical …

Atypical (WHO grade II) meningiomas occupy an intermediate risk group between benign
(WHO grade I) and anaplastic (WHO grade III) meningiomas. Although grade II …

Background Magnetic resonance spectroscopy (MRS) is an established tool for in-vivo
evaluation of the biochemical basis of human diseases. On one hand, such lucid depiction …

Anaplastic or malignant meningiomas (WHO Grade III) represent the most rare but
aggressive subtype, accounting for 1–3% of all intracranial meningiomas. Due in large part …

Background Meningiomas arise from the arachnoid meningothelial cells. Intracranially, they
are extra-axial masses that are typically T1 isointense to slightly hypointense and T2 …

Atypical and malignant meningiomas are more likely to recur than benign meningiomas. We
aimed to distinguish atypical and malignant meningiomas from benign meningiomas based …

In vivo NMR spectroscopy is known as magnetic resonance spectroscopy (MRS). MRS has
been applied as both a research and a clinical tool in order to detect visible or nonvisible …

Objective Solitary fibrous tumor/hemangiopericytoma (SFT/HPC) and meningioma exhibit
similar radiographic features; however, they differ in their prognoses. Preoperative …

Brain tumors represent 1.4% of all new cases of cancer in the United States annually, but
underlie 2.4% of all deaths caused by cancer. 1 Most brain tumors diagnosed are metastatic; …